Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
Clinical trial NCT00540293 · COMPLETED
Trial details
- NCT number
- NCT00540293
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-05-01
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.